BioScrip Investors Lose Suit After Targeting Different Board
A once-rejected investor lawsuit seeking damages on behalf of BioScrip Inc. for alleged director and consultant liability in False Claims Act kickback and fraud schemes on Tuesday failed again in Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article